Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for early primary hyperuricemia with renal underexcretion
ChiCTR2000035495Phase 4Not yet recruiting
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hyperuricemia comparing Hydroxychloroquine + lifestyle management with Placebo + lifestyle management (2 arms). Primary endpoints: Urinary urate excretion, Serum urate and 2 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on ChiCTR2000035495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035495.